Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.82USD
20 Sep 2018
Change (% chg)

$-0.01 (-0.98%)
Prev Close
$0.83
Open
$0.88
Day's High
$0.88
Day's Low
$0.82
Volume
187,651
Avg. Vol
174,371
52-wk High
$5.03
52-wk Low
$0.78

Chart for

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.29 -- --
ROI: -105.74 1.78 14.61
ROE: -116.33 3.27 16.33

BRIEF-Advaxis Announces Executive Leadership Changes

* ADVAXIS INC - KENNETH BERLIN HAS BEEN APPOINTED AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

23 Apr 2018

Earnings vs. Estimates